Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine save search
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Published: 2021-07-23 (Crawled : 13:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: 0.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 2.15%
H: 1.85%
C: -1.77%
covid vaccine
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Published: 2021-07-23 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: 0.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 2.15%
H: 1.85%
C: -1.77%
covid vaccine
COVID-19: Vaccines vs. Delta Variant, CDC Predicts Rising Death Toll in Unvaccinated and More
Published: 2021-07-22 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.08%
H: 1.01%
C: 0.37%
covid vaccine covid-19
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023
Published: 2021-07-22 (Crawled : 15:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -0.66%
H: 3.32%
C: 1.4%
covid vaccine
GeoVax Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting
Published: 2021-07-22 (Crawled : 13:15) - globenewswire.com
GOVX | $1.54 1.27% 35K
|
Health Technology
|
| O: 10.14%
H: 3.97%
C: -3.56%
presentation vaccine
Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial
Published: 2021-07-21 (Crawled : 13:00) - oramed.com
ORMP A | $2.375 1.06% 1.05% 41K
|
Health Technology
|
| O: 1.39%
H: 9.85%
C: 8.15%
vaccine trial approval
Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping TechnologyAlliance to expand the range of therapeutic and vaccine applications for the BioXp™ system
Published: 2021-07-21 (Crawled : 12:00) - biospace.com/
MRVI 4 | $7.68 -0.52% -0.52% 1.3M
|
Commercial Services
|
| O: -0.57%
H: 2.63%
C: 2.16%
biotech vaccine technology iot license
Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
Published: 2021-07-21 (Crawled : 12:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: -0.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.06%
H: 0.38%
C: 0.25%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.09%
H: 6.87%
C: 5.98%
covid collaboration vaccine announces collaboration africa
Ocugen's BLA for COVID-19 Vaccine Leads to Class Action Lawsuit
Published: 2021-07-20 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
covid vaccine covid-19
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022
Published: 2021-07-20 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.83%
H: 0.53%
C: -0.06%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 1.48%
H: 7.63%
C: -3.42%
covid vaccine
Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines
Published: 2021-07-19 (Crawled : 00:00) - fda.gov
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
vaccine
Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate
Published: 2021-07-19 (Crawled : 05:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.17%
H: 0.7%
C: 0.2%
disease phase 2 vaccine trial
To Combat COVID-19 Vaccine Hesitancy in Black Community, Twin Sister Doctors Develop Strategy
Published: 2021-07-16 (Crawled : 11:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
covid vaccine covid-19
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
Published: 2021-07-15 (Crawled : 22:00) - globenewswire.com
IBIO | $1.9 0.0% 99K
|
Health Technology
|
| O: 3.05%
H: 3.7%
C: -2.22%
covid leo vaccine preclinical covid-19 pre-clinical
Global COVID-19 Vaccines Market Report 2021-2026: Overview, Epidemiology, Marketed Vaccines, Unmet Needs, Pipeline Assessment, and Outlook
Published: 2021-07-15 (Crawled : 19:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
covid vaccine
PagerDuty Deploys $1M To Help Close The COVID-19 Global Vaccine Equity Gap by Olivia Khalili
Published: 2021-07-15 (Crawled : 16:00) - pagerduty.com
PD | News | $20.76 -1.38% 0.0% 1.1M
|
Technology Services
|
| O: 0.13%
H: 1.44%
C: -3.74%
covid vaccine covid-19
Celsion Corporation Expands Vaccine Advisory Board with the Addition of Dr. Dan H. Barouch and Dr. Luke D. Handke
Published: 2021-07-15 (Crawled : 14:15) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.35%
C: -0.55%
vaccine
Cigna International finds community spirit and duty to society top driver of COVID-19 vaccine uptake
Published: 2021-07-15 (Crawled : 07:00) - prnewswire.com
CI | $352.28 -0.11% 0.0% 1.1M
|
Health Services
|
| O: -0.7%
H: 0.67%
C: 0.23%
covid vaccine covid-19
UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices
Published: 2021-07-14 (Crawled : 20:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.49%
C: 0.25%
covid vaccine covid-19
ImmunityBio Announces Authorization to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19
Published: 2021-07-14 (Crawled : 13:15) - biospace.com/
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: 0.77%
H: 1.35%
C: -5.32%
covid phase 1 vaccine trial t-cell authorized africa
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.